Michael Templin Ph.D Overview
- Company
- Adhera Therapeut...
- Primary Position
-
Chief Technology...
Michael Templin Ph.D General Information
Biography
Dr. Michael Templin served as Chief Technology Officer & Senior Vice President at Adhera Therapeutics. He joined Marina Biotech in December 2004. While at Marina Biotech (and its predecessors) he has served in a variety of management positions leading teams in the areas of discovery research and preclinical development. Before joining Marina Biotech he held research and development positions at Isis Pharmaceuticals, Amgen, and Zymogenetics. Dr. Templin's pharmaceutical development experience includes regulatory toxicology from bench research through IND and NDA filings for small- and large-molecule platforms (oligonucleotides, peptides, proteins, and antibodies). Dr. Templin received a Ph.D. in Pharmacology/Toxicology from Washington State University and completed a Postdoctoral Fellowship at the Chemical Industry Institute of Toxicology (RTP, NC Dr. Templin has held certification as a Diplomate of the American Board of Toxicology since 1998.
Contact Information
Michael Templin Ph.D FAQs
-
Who is Michael Templin Ph.D?
Dr. Michael Templin served as Chief Technology Officer & Senior Vice President at Adhera Therapeutics.
-
How much does Michael Templin Ph.D typically invest?
Michael Templin Ph.D's median deal size is .
-
What is Michael Templin Ph.D’s main position?
Michael Templin Ph.D’s primary position is Chief Technology Officer & Senior Vice President.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
